Company
United StatesPublic company, NASDAQ: KRYSKrystal Biotech, Inc. (NASDAQ: KRYS), Suite 701, Pittsburgh – FDA Inspections
Inspection records and compliance data for Krystal Biotech, Inc. in Suite 701, Pittsburgh. 1 FDA inspection on record, 1 Form 483, last inspected January 30, 2025. Publicly traded as NASDAQ: KRYS.
Company Profile
This profile covers Krystal Biotech, Inc. based in Suite 701, Pittsburgh, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected January 30, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 30, 2025 | Not classified | Biologics | 1259522 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Krystal Biotech, Inc.
Stock ticker
KRYS
Exchange
NASDAQ
Share price
$305.68
Market cap
$9.1B
Price as of
November 13, 2026
FEI Number
3013498720
Address
2100 Wharton Street, Suite 701, Pittsburgh, United States
Country
United States
ID: a9722688-fbec-493a-b344-89b3fb41b9ab